Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Advances in Pharmacology (San Diego, Calif.)
|
September 24, 2013
The enduring centrality of dopamine in the pathophysiology of schizophrenia: in vivo evidence from the prodrome to the first psychotic episode
Ilaria Bonoldi, O D Howes
Journal of Psychopharmacology (Oxford, England)
|
September 11, 2004
Diabetic keto-acidotic (DKA) coma following olanzapine initiation in a previously euglycaemic woman and successful continued therapy with olanzapine
O D Howes, L Rifkin
CNS Drugs
|
June 13, 2014
Presynaptic dopaminergic function: implications for understanding treatment response in psychosis
I Bonoldi, O D Howes
Translational Psychiatry
|
February 8, 2017
Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization
O D Howes, R McCutcheon
International Journal of Psychiatry in Clinical Practice
|
June 13, 2014
Manic psychosis induced by long term alpha-interferon treatment for hepatitis C
O D Howes Kwame J McKenzie
Lancet (London, England)
|
June 27, 1998
Health anxiety in medical students
O D Howes, P M Salkovskis
Psychopharmacology
|
July 13, 2016
Fronto-limbic engagement during moral processing in stimulant users
N J Blackwood, O D Howes
Molecular Psychiatry
|
October 4, 2017
The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders
M Kokkinou, A H Ashok, O D Howes
BMC Psychiatry
|
October 25, 2019
Making decisions about antipsychotics: a qualitative study of patient experience and the development of a decision aid
S J Kaar, C Gobjila, E Butler, et al.
Current Pharmaceutical Design
|
January 14, 2012
From the prodrome to chronic schizophrenia: the neurobiology underlying psychotic symptoms and cognitive impairments
O D Howes, P Fusar-Poli, M Bloomfield, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Advances in Pharmacology (San Diego, Calif.)
|
September 24, 2013
The enduring centrality of dopamine in the pathophysiology of schizophrenia: in vivo evidence from the prodrome to the first psychotic episode
Ilaria Bonoldi, O D Howes
Journal of Psychopharmacology (Oxford, England)
|
September 11, 2004
Diabetic keto-acidotic (DKA) coma following olanzapine initiation in a previously euglycaemic woman and successful continued therapy with olanzapine
O D Howes, L Rifkin
CNS Drugs
|
June 13, 2014
Presynaptic dopaminergic function: implications for understanding treatment response in psychosis
I Bonoldi, O D Howes
Translational Psychiatry
|
February 8, 2017
Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization
O D Howes, R McCutcheon
International Journal of Psychiatry in Clinical Practice
|
June 13, 2014
Manic psychosis induced by long term alpha-interferon treatment for hepatitis C
O D Howes Kwame J McKenzie
Lancet (London, England)
|
June 27, 1998
Health anxiety in medical students
O D Howes, P M Salkovskis
Psychopharmacology
|
July 13, 2016
Fronto-limbic engagement during moral processing in stimulant users
N J Blackwood, O D Howes
Molecular Psychiatry
|
October 4, 2017
The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders
M Kokkinou, A H Ashok, O D Howes
BMC Psychiatry
|
October 25, 2019
Making decisions about antipsychotics: a qualitative study of patient experience and the development of a decision aid
S J Kaar, C Gobjila, E Butler, et al.
Current Pharmaceutical Design
|
January 14, 2012
From the prodrome to chronic schizophrenia: the neurobiology underlying psychotic symptoms and cognitive impairments
O D Howes, P Fusar-Poli, M Bloomfield, et al.
Page
of 3